Literature DB >> 24607931

Role of FK506 binding protein 12 in morphine-induced μ-opioid receptor internalization and desensitization.

Ying-Hui Yan1, Yan Wang1, Lan-Xue Zhao1, Shan Jiang1, Horace H Loh2, Ping-Yee Law2, Hong-Zhuan Chen1, Yu Qiu1.   

Abstract

Agonist-activated μ-opioid receptor (OPRM1) undergoes robust receptor phosphorylation by G protein-coupled receptor kinases and subsequent β-arrestin recruitment, triggering receptor internalization and desensitization. Morphine, a widely prescribed opioid, induces receptor phosphorylation inefficiently. Previously we reported that FK506 binding protein 12 (FKBP12) specifically interacts with OPRM1 and such interaction attenuates receptor phosphorylation and facilitates morphine-induced recruitment and activation of protein kinase C. In the current study, we demonstrated that the association of FKBP12 with OPRM1 also affects morphine-induced receptor internalization and G protein-dependent adenylyl cyclase desensitization. Morphine induced faster receptor internalization and adenylyl cyclase desensitization in cells expressing OPRM1 with Pro(353) mutated to Ala (OPRM1P353A), which does not interact with FKBP12, or in the presence of FK506 which dissociates the receptor-FKBP12 interaction. Furthermore, knockdown of cellular FKBP12 level by siRNA accelerated morphine-induced receptor internalization and adenylyl cyclase desensitization. Our study further demonstrated that peptidyl prolyl cis-trans isomerase activity of FKBP12 probably plays a role in inhibition of receptor phosphorylation. In the view that internalized receptor recycles and thus counteracts the development of analgesic tolerance, receptor's association with FKBP12 could also contribute to the development of morphine tolerance through modulation of receptor trafficking.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Desensitization; FK506 binding protein 12; Internalization; Morphine; μ-Opioid receptor

Mesh:

Substances:

Year:  2014        PMID: 24607931      PMCID: PMC4010564          DOI: 10.1016/j.neulet.2014.02.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

1.  Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.

Authors:  J L Whistler; H H Chuang; P Chu; L Y Jan; M von Zastrow
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

2.  Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling.

Authors:  Ying-Jian Liang; Dai-Fei Wu; Li-Quan Yang; Volker Höllt; Thomas Koch
Journal:  Mol Pharmacol       Date:  2006-09-27       Impact factor: 4.436

3.  Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail.

Authors:  Y Pak; B F O'Dowd; S R George
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

4.  Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling.

Authors:  Dai-Fei Wu; Thomas Koch; Ying-Jian Liang; Ralf Stumm; Stefan Schulz; Helmut Schröder; Volker Höllt
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

5.  An internal FK506-binding domain is the catalytic core of the prolyl isomerase activity associated with the Bacillus subtilis trigger factor.

Authors:  S F Göthel; R Schmid; A Wipat; N M Carter; P T Emmerson; C R Harwood; M A Marahiel
Journal:  Eur J Biochem       Date:  1997-02-15

6.  Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area.

Authors:  Colleen A McClung; Eric J Nestler; Venetia Zachariou
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

Review 7.  Opioids: first lessons from knockout mice.

Authors:  B L Kieffer
Journal:  Trends Pharmacol Sci       Date:  1999-01       Impact factor: 14.819

8.  Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.

Authors:  Patricia A Claude-Geppert; Jiahui Liu; Jonathan Solberg; Laurie J Erickson-Herbrandson; Horace H Loh; Ping-Yee Law
Journal:  J Pharmacol Exp Ther       Date:  2004-12-03       Impact factor: 4.030

9.  Receptor endocytosis counteracts the development of opioid tolerance.

Authors:  Thomas Koch; Antje Widera; Katharina Bartzsch; Stefan Schulz; Lars-Ove Brandenburg; Nicole Wundrack; Andrea Beyer; Gisela Grecksch; Volker Höllt
Journal:  Mol Pharmacol       Date:  2004-10-08       Impact factor: 4.436

10.  Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism.

Authors:  T M Palmer; J L Benovic; G L Stiles
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  4 in total

1.  Post-Transcriptional Regulation of the Human Mu-Opioid Receptor (MOR) by Morphine-Induced RNA Binding Proteins hnRNP K and PCBP1.

Authors:  Kyu Young Song; Hack Sun Choi; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Cell Physiol       Date:  2016-06-24       Impact factor: 6.384

Review 2.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 3.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

4.  siRNA capsulated brain-targeted nanoparticles specifically knock down OATP2B1 in mice: a mechanism for acute morphine tolerance suppression.

Authors:  Zi-Zhao Yang; Li Li; Lu Wang; Ming-Cheng Xu; Sai An; Chen Jiang; Jing-Kai Gu; Zai-Jie Jim Wang; Lu-Shan Yu; Su Zeng
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.